BIIB - BIOGEN INC.
118.17
-0.220 -0.186%
Share volume: 1,306,441
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$118.39
-0.22
0.00%
Summary score
69%
Profitability
84%
Dept financing
43%
Liquidity
29%
Performance
70%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2013 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
6.7%
Return on assets
5.14%
Return on sales
42.33%
Return on invested capital
6.9%
Total debt ratio
46.59%
Debt ratio change over timeo
0%
Current Ratio
2.53%
Quick Ratio
2.21%
Cash Position Ratio
0.5%
Short-term ratios 31-Dec-2016 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
5.28%
Return on assets
4.87%
Return on sales
39.73%
Return on invested capital
5.5%
Total debt ratio
45.88%
Debt ratio change over timeo
0%
Current Ratio
2.23%
Quick Ratio
1.95%
Cash Position Ratio
0.39%
Last quarter ratios 31-Dec-2017
The data are presented for the financials results of the last quarter.
Return on equity
-2.36%
Return on assets
5.26%
Return on sales
41.44%
Return on invested capital
-2.4%
Total debt ratio
46.67%
Debt ratio change over time
0%
Current Ratio
2.34%
Quick Ratio
2.07%
Cash Position Ratio
0.47%
Performance ratios (change over 4 years) 31-Dec-2013 - 31-Dec-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BIIB | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 6.7% | 3.6% | 11.07% | 0% |
| Return on assets | 5.14% | 3.16% | 6.86% | 0% |
| Return on sales | 42.33% | 43.39% | 56.58% | 0% |
| Return on invested capital | 6.9% | 5.43% | 9.14% | 0% |
| Profitability | 71% | 54% | 100% | 0% |
| Total debt ratio | 46.59% | 61.64% | 66.49% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 43% | 23% | 25% | 0% |
| Current Ratio | 2.23% | 5.54% | 3.09% | 0% |
| Quick Ratio | 1.95% | 5.21% | 2.96% | 0% |
| Cash Position Ratio | 0.39% | 0.36% | 1.43% | 0% |
| Liquididy | 35% | 57% | 51% | 0% |
| Short-term ratios | BIIB | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 5.28% | 0.73% | 4.7% | 0% |
| Return on assets | 4.87% | 3.16% | 5.67% | 0% |
| Return on sales | 39.73% | 44.06% | 53.59% | 0% |
| Return on invested capital | 5.5% | 2.07% | 5.57% | 0% |
| Profitability | 90% | 47% | 97% | 0% |
| Total debt ratio | 45.88% | 62.28% | 64.86% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 43% | 24% | 25% | 0% |
| Current Ratio | 2.23% | 5.54% | 3.09% | 0% |
| Quick Ratio | 1.95% | 5.21% | 2.96% | 0% |
| Cash Position Ratio | 0.39% | 0.36% | 1.43% | 0% |
| Liquididy | 26% | 56% | 53% | 0% |
